Pharmacology/Pharmaceutical Industry
Guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care.
21 Mar, 2022 | 10:02h | UTC
Infographic: IDSA COVID-19 outpatient treatment guidelines roadmap.
21 Mar, 2022 | 09:51h | UTCCOVID-19 Outpatient Treatment Guidelines Roadmap – Infectious Diseases Society of America
Commentary on Twitter
IDSA and @RealTimeCOVID19's new visual clinical flowchart summarizes outpatient COVID-19 treatment options and guidance.
📄:https://t.co/NTo1nNlfDr #RealTimeCOVID19 @CDCgov pic.twitter.com/CXz1tgpJ05
— IDSA (@IDSAInfo) March 19, 2022
CDC Report: Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death in the US.
21 Mar, 2022 | 09:38h | UTCCommentary: Studies show vaccines protect against serious Omicron illness – CIDRAP
Commentary on Twitter
New @CDCMMWR study finds #COVID19 vaccines continued to be highly effective at protecting adults from being put on a ventilator or dying during Omicron. All eligible adults should stay up to date w/ COVID-19 vaccines to protect against severe disease. https://t.co/nLi7B2SLJy pic.twitter.com/4o35Vhjg1K
— CDC (@CDCgov) March 18, 2022
Effectiveness of the Johnson & Johnson vaccine in health-care workers in South Africa in a period when the beta and then the delta SARS-CoV-2 variants of concerns were dominant.
21 Mar, 2022 | 09:43h | UTCInvited Commentary: Sisonke: reaching several goals together – The Lancet
Commentary on Twitter (thread – click for more)
Single-dose Ad26.COV2.S vaccine in healthcare workers in South Africa shows effectiveness against severe #COVID19 outcomes—and against beta and delta variants, study indicates.https://t.co/S13Ia1H8BT pic.twitter.com/XgbXGcT9XR
— The Lancet (@TheLancet) March 19, 2022
Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.
21 Mar, 2022 | 09:37h | UTCMyocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel – JAMA
Related:
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Systematic Review: Strategies for using topical corticosteroids in children and adults with eczema.
21 Mar, 2022 | 08:33h | UTCStrategies for using topical corticosteroids in children and adults with eczema – Cochrane Library
Summary: What is the best way to use topical corticosteroids to treat people with eczema? – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1504548242738102273
RCT: Oral contezolid vs. linezolid in adults with complicated skin and soft tissue infections.
18 Mar, 2022 | 07:54h | UTCA Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link to abstract – $ for full-text)
Commentary on Twitter
Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
📌Non inferior
📌Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
📌QIDP https://t.co/wSvxUInnkZ— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) March 11, 2022
Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.
17 Mar, 2022 | 09:12h | UTCEfficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine
Related: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Effectiveness of the Sputnik V, AstraZeneca, and Sinopharm vaccines for the risk of infection and death due to COVID-19 in people older than 60 years in Argentina.
17 Mar, 2022 | 09:10h | UTCCommentary: Evaluating COVID-19 vaccines in the real world – The Lancet
Treatments for mild COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:17h | UTCTreatments for mild COVID-19: Cochrane evidence – Cochrane Library
[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.
17 Mar, 2022 | 09:07h | UTC
Commentary on Twitter
Details of the design & pt characteristics now published:
6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9— Martin Landray (@MartinLandray) March 16, 2022
Review: Mechanistic and clinical overview of cardiovascular toxicity with BRAF and MEK inhibitors.
17 Mar, 2022 | 08:34h | UTC
Commentary on Twitter
New #JACCCardioOnc issue is out!
BRAF/MEK inhibitors are associated w/ adverse CV effects including HTN, LV dysfunction, #VTE, atrial arrhythmias, & QT prolongation. Learn more in this state-of-the-art review: https://t.co/2r9L90DTmL#CardioOnc #CardioTwitter #Hypertension pic.twitter.com/Dz8i0sfBTU
— JACC Journals (@JACCJournals) March 15, 2022
Trends in HPV–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017.
17 Mar, 2022 | 08:16h | UTCAuthor Interview: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations
Related:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
Cohort Study: TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
16 Mar, 2022 | 08:44h | UTC
Most antibiotic prophylaxis prescriptions prior to dental visits are inconsistent with guidelines.
16 Mar, 2022 | 08:33h | UTCAntibiotic prophylaxis prescriptions prior to dental visits in the Veterans’ Health Administration (VHA), 2015–2019 – Infection Control & Hospital Epidemiology (link to abstract – $ for full-text)
Commentary: Most antibiotics prescribed for dental visits inconsistent with guidelines, study finds – Healio (link to abstract – $ for full-text)
Commentary on Twitter
New in @ICHEJournal from @SUDAmonas et al:
➡️ Five out of six antibiotics prescribed for dental infection prophylaxis in VA were inconsistent with guidelines. Improving prophylaxis appropriateness may have large implications for stewardship.
📄: https://t.co/HTTO9eaYo5 pic.twitter.com/Ay9zgJIqml
— Infection Control & Hospital Epidemiology (@ICHEJournal) February 23, 2022
M-A: Intraoperative redosing of surgical antibiotic prophylaxis in addition to preoperative prophylaxis vs. single-dose prophylaxis for the prevention of surgical site infection.
16 Mar, 2022 | 08:34h | UTC
M-A: Evaluating the association between LDL Cholesterol reduction and relative and absolute effects of statin treatment.
15 Mar, 2022 | 10:04h | UTCEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary from the author: Benefits of statins may have been overstated – new study – The Conversation
Commentary on Twitter
Our study in @JAMAInternalMed asked 2 questions 1. Is reducing one’s ‘bad’ cholesterol was associated with a proportional reduction in death, heart attack and stroke? 2. What's the absolute reduction in risk from taking statins? https://t.co/Zwh7LmUD0e
— Dr Paula Byrne (@pbyrne82) March 14, 2022
Review: Drug-induced acute kidney injury.
14 Mar, 2022 | 00:48h | UTCDrug-Induced Acute Kidney Injury – Clinical Journal of the American Society of Nephrology
RCT: Methenamine Hippurate (a non-antibiotic preventive treatment) is noninferior to prophylactic antibiotics for treating recurrent urinary tract infections in women.
11 Mar, 2022 | 10:21h | UTCNews Release: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom
Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ
Commentaries:
Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay
Commentary on Twitter
https://twitter.com/bmj_latest/status/1501800030608494596
Another study suggests that a third vaccine dose is necessary to protect populations against the omicron variant.
11 Mar, 2022 | 10:14h | UTCNews Release: Third vaccine dose critical for protecting populations against omicron variant – BMJ Newsroom
Commentary on Twitter
mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But three doses are needed to achieve a similar level of protection against omicron, finds a large US study: https://t.co/YMm176gmby
— The BMJ (@bmj_latest) March 10, 2022
Association between statin use and daptomycin-related musculoskeletal adverse events: A mixed approach combining a meta-analysis and a disproportionality analysis.
11 Mar, 2022 | 09:39h | UTC
Meta-analysis of randomized trials: benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery.
10 Mar, 2022 | 10:48h | UTC
Commentary on Twitter
https://twitter.com/KariTikkinen/status/1501532156786577415
Updated guideline summary introduces new recommendations for use of medications around total hip and knee replacement.
10 Mar, 2022 | 10:45h | UTCGuideline Summary (full guideline not available yet): 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty – American College of Rheumatology
Extending the reach of antimicrobial stewardship to pediatric patients.
10 Mar, 2022 | 10:12h | UTC
RCT: Reliever-triggered inhaled glucocorticoid reduces severe exacerbations in black and latinx adults with moderate-to-severe asthma.
9 Mar, 2022 | 10:06h | UTCReliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma – New England Journal of Medicine (link to abstract – $ for full-text)


